Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Jul;158(1):146-9.
doi: 10.1111/j.1365-2141.2012.09110.x. Epub 2012 Apr 2.

Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia

Case Reports

Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia

Bradley N Smith et al. Br J Haematol. 2012 Jul.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig 1
WAVE chromatograms, restriction enzyme digests and haplotype study of G6PC3 mutant-positive kindreds. (A) WAVE chromatograms of exon 1 and exon 5 polymerase chain reaction (PCR) products from mutation-positive patients mixed with known wild-type (WT) PCR products. (B) (i) PCR products of Patient 1, his affected sister and parents carrying the c.190_210del mutation. (ii) TaqI digestion confirming the c.623T>G mutation in Patient 2 and her parents. (iii) DdeI digestion of PCR products confirming the c.130C>T mutation in Patients 3 and 4. Parental results (lanes 3 and 4) were the same for both patients. (C) Microsatellite and SNP analysis of the G6PC3 locus in kindreds 3 and 4 with the c.130C>T mutation. The shared haplotype flanked by markers D17S951 and D17S1827 is highlighted.
Fig 2
Fig 2
Percentage of non-viable neutrophils in patients with the p.Thr64_Ile70del and p.Pro44Ser mutations, their carrier parents and controls. Graphical representation of the percentage of non-viable neutrophils (Annexin V-positive, propidium iodide-negative plus Annexin V-positive propidium iodide-positive cells) from patients, parents and controls after incubation for up to 3 h either untreated or in the presence of 5 μmol/l staurosporine.

References

    1. Arostegui JI, de Toledo JS, Pascal M, Garcia C, Yague J, Diaz de Heredia C. A novel G6PC3 homozygous 1-bp deletion as a cause of severe congenital neutropenia. Blood. 2009;114:1718–1719. - PubMed
    1. Banka S, Chervinsky E, Newman WG, Crow YJ, Yeganeh S, Yacobovich J, Donnai D, Shalev S. Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3. European Journal of Human Genetics. 2011a;19:18–22. - PMC - PubMed
    1. Banka S, Wynn R, Newman WG. Variability of bone marrow morphology in G6PC3 mutations: is there a genotype-phenotype correlation or age-dependent relationship? American Journal of Hematology. 2011b;86:235–237. - PubMed
    1. Boztug K, Appaswamy G, Ashikov A, Schaffer AA, Salzer U, Diestelhorst J, Germeshausen M, Brandes G, Lee-Gossler J, Noyan F, Gatzke AK, Minkov M, Greil J, Kratz C, Petropoulou T, Pellier I, Bellanne-Chantelot C, Rezaei N, Monkemoller K, Irani-Hakimeh N, Bakker H, Gerardy-Schahn R, Zeidler C, Grimbacher B, Welte K, Klein C. A syndrome with congenital neutropenia and mutations in G6PC3. New England Journal of Medicine. 2009;360:32–43. - PMC - PubMed
    1. Boztug K, Rosenberg PS, Dorda M, Banka S, Moulton T, Curtin J, Rezaei N, Corns J, Innis JW, Avci Z, Tran HC, Pellier I, Pierani P, Fruge R, Parvaneh N, Mamishi S, Mody R, Darbyshire P, Motwani J, Murray J, Buchanan GR, Newman WG, Alter BP, Boxer LA, Donadieu J, Welte K, Klein C. Extended Spectrum of Human Glucose-6-Phosphatase Catalytic Subunit 3 Deficiency: Novel Genotypes and Phenotypic Variability in Severe Congenital Neutropenia. Journal of Pediatrics. 2012;12:679–683. e2. - PubMed

Supplementary concepts

LinkOut - more resources